These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 17098043

  • 1. Sirolimus attenuates chronic allograft nephropathy in an experimental rat kidney transplantation model.
    Savikko J, von Willebrand E.
    Transplant Proc; 2006 Oct; 38(8):2699-700. PubMed ID: 17098043
    [Abstract] [Full Text] [Related]

  • 2. Early short-term platelet-derived growth factor inhibition prevents the development of chronic allograft nephropathy in experimental rat kidney transplantation.
    Savikko J, Rintala J, von Willebrand E.
    Transplant Proc; 2006 Dec; 38(10):3231-2. PubMed ID: 17175231
    [Abstract] [Full Text] [Related]

  • 3. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM, Savikko J, Rintala SE, von Willebrand E.
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [Abstract] [Full Text] [Related]

  • 4. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM, Savikko J, Rintala SE, von Willebrand E.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [Abstract] [Full Text] [Related]

  • 5. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
    Savikko J, Taskinen E, Von Willebrand E.
    Transplantation; 2003 Apr 27; 75(8):1147-53. PubMed ID: 12717194
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection.
    Rintala SE, Savikko J, Rintala JM, von Willebrand E.
    Transplant Proc; 2006 Dec 27; 38(10):3236-8. PubMed ID: 17175233
    [Abstract] [Full Text] [Related]

  • 7. Sirolimus inhibits lymphangiogenesis in rat renal allografts, a novel mechanism to prevent chronic kidney allograft injury.
    Palin NK, Savikko J, Koskinen PK.
    Transpl Int; 2013 Feb 27; 26(2):195-205. PubMed ID: 23167600
    [Abstract] [Full Text] [Related]

  • 8. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy.
    Falger JC, Mueller T, Arbeiter K, Boehm M, Regele H, Balzar E, Aufricht C.
    Pediatr Transplant; 2006 Jun 27; 10(4):474-8. PubMed ID: 16712606
    [Abstract] [Full Text] [Related]

  • 9. Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients.
    Stallone G, Di Paolo S, Schena A, Infante B, Grandaliano G, Battaglia M, Gesualdo L, Schena FP.
    Transplantation; 2003 Apr 15; 75(7):998-1003. PubMed ID: 12698087
    [Abstract] [Full Text] [Related]

  • 10. Early short-term imatinib treatment is sufficient to prevent the development of chronic allograft nephropathy.
    Savikko J, Rintala JM, Rintala SE, Koskinen PK, von Willebrand E.
    Nephrol Dial Transplant; 2011 Sep 15; 26(9):3026-32. PubMed ID: 21285128
    [Abstract] [Full Text] [Related]

  • 11. Rapamycin and cyclosporine have different effects on expression of Ang-1 and Ang-2 and Tie2 in rat renal allograft with chronic allograft nephropathy.
    Ma X, Lu YP, Yang L, Song J, Luo GH, Shi YJ, Li YP.
    Transplant Proc; 2008 Oct 15; 40(8):2804-7. PubMed ID: 18929866
    [Abstract] [Full Text] [Related]

  • 12. The effect of sirolimus in the development of chronic allograft nephropathy.
    Gürkan A, Kaçar S, Erdoğdu U, Varilsüha C, Kandemir G, Karaca C, Akman F.
    Transplant Proc; 2008 Oct 15; 40(1):114-6. PubMed ID: 18261561
    [Abstract] [Full Text] [Related]

  • 13. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J.
    Transplant Proc; 2008 Dec 15; 40(10):3731-6. PubMed ID: 19100477
    [Abstract] [Full Text] [Related]

  • 14. Is sirolimus a safe alternative to reduce or eliminate calcineurin inhibitors in chronic allograft nephropathy in kidney transplantation?
    Lai WJ, Chiang YJ, Chen Y, Chu SH.
    Transplant Proc; 2004 Sep 15; 36(7):2056-7. PubMed ID: 15518744
    [Abstract] [Full Text] [Related]

  • 15. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
    Rintala JM, Savikko J, Rintala SE, von Willebrand E.
    Transplant Proc; 2006 Oct 15; 38(8):2719-21. PubMed ID: 17098049
    [Abstract] [Full Text] [Related]

  • 16. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 17. Five-year follow-up after late conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction.
    Krüger B, Fischereder M, Jauch KW, Graeb C, Hoffmann U, Böger CA, Banas B, Obed A, Schlitt HJ, Krämer BK.
    Transplant Proc; 2007 Mar 15; 39(2):518-21. PubMed ID: 17362772
    [Abstract] [Full Text] [Related]

  • 18. Detection of citrate synthase autoantibodies in rats with chronic allograft nephropathy.
    Zhang LY, Lu YP, Yang L, Luo GH, Song J, Li YP.
    Transplant Proc; 2009 Dec 15; 41(10):4366-8. PubMed ID: 20005400
    [Abstract] [Full Text] [Related]

  • 19. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients.
    Boratyńska M, Banasik M, Watorek E, Falkiewicz K, Patrzałek D, Szyber P, Klinger M.
    Transplant Proc; 2006 Dec 15; 38(1):101-4. PubMed ID: 16504675
    [Abstract] [Full Text] [Related]

  • 20. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.
    Nephrology (Carlton); 2008 Feb 15; 13(1):80-6. PubMed ID: 18199109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.